42
Participants
Start Date
August 27, 2019
Primary Completion Date
August 1, 2020
Study Completion Date
August 10, 2020
Intranasal Dexmedetomidine
The mucosal atomizing device will be used intranasally where the sedative drug will be equally divided and sprayed into each nostril while the child semi reclined position.
Sublingual Dexmedetomidine
The mucosal atomizing device will be used sublingually by asking the child to touch their maxillary incisor teeth with the tip of their tongue and instruct the child not to swallow the drug for 30 seconds.
Faculty of Dentistry, Alexandria University, Alexandria
Alexandria University
OTHER
Nourhan M.Aly
OTHER